VipStockReports

Bearish Stocks at Healthcare - Abbott Laboratories (NYSE:ABT), Bristol-Myers Squibb Co (NYSE:BMY), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Pfizer Inc. (NYSE:PFE)

 
Repost This

Middletown, DE -- (SBWIRE) -- 08/06/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Abbott Laboratories (NYSE:ABT), Bristol-Myers Squibb Co (NYSE:BMY), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Pfizer Inc. (NYSE:PFE)

Abbott Laboratories (NYSE:ABT) fell down -0.82% with the closing price of $36.45. The overall volume in the last trading session was 6.51 million shares. Its fifty two week range was $31.64-$72.47. The total market capitalization remained $56.82 billion. ABT is ahead its 52 week low with 23.05% and its last month price volatility remained 1.12%. Its beta coefficient was 0.36 with a target price of $40.56.

Has ABT Found The Bottom and Ready To Move Up? Find Out Here

Bristol-Myers Squibb Co (NYSE:BMY) plunged -0.50% to close at $43.62 and its total traded volume was 5.98 million shares. BMY has earnings per share of $0.83 and its price to earnings ratio is 52.55. BMY has market cap of 71.81 billion. Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.

Has BMY Found The Bottom And Ready To Gain Momentum? Find Out Here

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)dropped -1.00% and closed at $38.51 with the overall traded volume of 5.45 million shares. Stock price 52 weeks low was $36.63 and 52 weeks high price was $42.83. Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories.

Why Should Investors Buy TEVA After the Recent Fall? Just Go Here and Find Out

Pfizer Inc. (NYSE:PFE) declined -0.61% and closed at $29.19 in the last trading session with the overall traded volume of 14.39 million shares. PFE has earnings per share of $1.47 and its price to earnings ratio is 19.79. PFE has market cap of 207.05 billion and its beta value stands at 0.71 times.

Will PFE Get Buyers Even After The Recent Rally? Find Out Here

About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!

Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.

Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.

VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.

Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/